ended September 30, 2019 respectively. The main reason of the reduction of those ratios is the company and its subsidiaries have debenture which is to be redeemed within July 2020 then this debenture has

available to pay debt securities holders; b. provision requiring the issuer to maintain certain financial ratios; c. provision that restrict the issuer from creating additional debt under certain conditions

marketplace platforms, extends payment channels, implements a delivery tracking system, introduces branded exclusive products in specific channels, and improves IT product advising services. Dealer sales

, engages in marketing activities with various marketplace platforms, extends payment channels, implements a delivery tracking system, introduces branded exclusive products in specific channels, and improves

buy more products. In addition, the company Has additional payment channels for products. Payment via True Money, credit card promotions, tracking product delivery, making exclusive products in

ratios stood at 68.47% and 72.47%, respectively. The higher ratio on a year-on-year basis was attributable to the Company having some costs in depreciation, personnel, drugs and medical supplies

December 31, 2019, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 71.17% and 68.84%, respectively. The lower ratio on a year-on-year basis was attributable to the Company

million in the year ended 31 December 2016 and the year ended 31 December 2017, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 65.69% and 66.64%, respectively. The

six-month period ended June 30, 2020, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 68.97% and 72.06% , respectively. The higher ratio on a period-on-period basis

failure to prepare and submit (1) the interim financial statements for the six-month period ended 30 June 2023 (2) the audited financial statements for the year 2023 (3) the key financial ratios for the